Showing results (271-280 of 308) with videos related to
Sort By:
Pageof 31
Annals of the Rheumatic Diseases|February 19, 2014
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trialFrank Behrens, Paul P Tak, Mikkel Østergaard, et al.Annals of the Rheumatic Diseases|November 27, 2010
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trialsMarleen G H van de Sande, Danielle M Gerlag, Beatrijs M Lodde, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytesPhilip H J Remans, Sonja I Gringhuis, Jacob M van Laar, et al.The Journal of Rheumatology|August 17, 2014
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritisWalter P Maksymowych, Stanley J Naides, Vivian Bykerk, et al.Annals of the Rheumatic Diseases|June 2, 2011
Animal models for arthritis: innovative tools for prevention and treatmentGeorge Kollias, Piyi Papadaki, Florence Apparailly, et al.Atherosclerosis|March 6, 2010
Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosisSander I van Leuven, Diederik F van Wijk, Oscar L Volger, et al.The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.Science Translational Medicine|October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitisWolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.The Journal of Rheumatology|June 17, 2018
Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA StudyAlberto Cauli, Dafna D Gladman, Alessandro Mathieu, et al.Annals of the Rheumatic Diseases|August 19, 2024
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE studyCynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.Pageof 31